Neurometrix Inc (NURO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NURO Annual Balance Sheets →
Quarterly balance sheet trends provide context on Neurometrix Inc's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Sep 30 2024) (Jun 30 2024) (Mar 31 2024) (Dec 31 2023)
Assets
Cash & cash equivalent1.43
Available-for-sale Securities, Debt Securities MA11.67
Cash & Short-term Investments12.00
Accounts receivable0.19
Inventories1.35
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.38
Total Current Assets15.01
Equipment/Property/Plant Net0.20
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.11
Operating Lease Right Of Use Asset0.11
Total Assets15.32
Liabilities
Accounts Payable, Current AC0.36
Accrued Liabilities, Current AC0.54
Other Liabilities, Current0.00
Total Current Liabilities1.01
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent-
Operating Lease Liability Current0.11
Total Liabilities1.01
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock232.17
Retained Earnings / Accumulated Deficit-217.92
Other Equity0.06
Common Stockholder's Equity14.31
Preferred Stockholder's Equity0.00
Total Stockholder's Equity14.31
Liabilities & Stockholder's Equity15.32
4 historic quarters locked

Sign in to unlock the full Neurometrix Inc balance sheet history.

About Neurometrix Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-24-045323

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.